Longboard Pharma (LBPH) Kapitalizatsiyaning foydaga nisbati

Longboard Pharma (LBPH) korporativ emblemasi va logotipi

Longboard Pharmaceuticals (LBPH) uchun bozor tendentsiyasi epilepsiya va og'ir miya patologiyalari uchun ilg'or, patent himoyasidagi davolash vositalarini ishlab chiqayotgan kompaniyaning dinamikasini aks ettiradi. Joriy ko'rsatkich -27.00 darajasida turibdi. Yagona asosiy loyihaga tayanilganiga qaramay, sezilarli kapital moliyaviy barqarorlikni ta'minlaydi. Brendning yuqori tibbiy nufuzi samarali sinovlar va noyob tashxislar olgan bemorlarga yordam ko'rsatishga asoslangan.

Longboard Pharmaceuticals - LBPH P/E multiplikatori (davr: 04.07.2022 - 07.12.2024)

Longboard Pharmaceuticals kompaniyasining tahliliy kesimlari

Kompaniyaning jamlanma tahlili:LBPH, longboardpharma.com
Longboard Pharmaceuticals, Inc. brendining mahsuloti

P/E koeffitsiyenti sof foydaning bir birligining bozor qiymatini o'lchaydi va investitsiyalarning qoplanish muddatini belgilaydi. Ushbu metrika joriy bozor kapitalizatsiyasini biznesning haqiqiy daromadliligi bilan solishtiradi. P/E tebranishlarini kuzatish orqali investor Longboard Pharmaceuticals (LBPH) kompaniyasining Yevropa sog'liqni saqlash giganti tomonidan sotib olinishi aktivlar baholashiga ko'rsatgan ta'sirini ko'rishi mumkin. Pipeline'ning xaridor tuzilmasiga integratsiyalashuvi klassik foyda tahlilini ikkinchi darajali qiladi. Ushbu ko'rsatkich endilikda M&A tranzaksiyasining yakunlanishi uchun marker vazifasini o'taydi.

Raqobatdosh kompaniyalar tahlili

Narxning foydaga nisbati BIIB|Narxning foydaga nisbati Neurocrine Biosciences, Inc. (NBIX)|RGC - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Axsome Therapeutics Inc AXSM|ACAD: Narx-foyda multiplikatori|Xenon Pharmaceuticals - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti vikingtherapeutics.com (VKTX)|SUPN: P/E multiplikatori|CPRX (Catalyst Pharma) - Narxning foydaga nisbati|Narxning foydaga nisbati Denali Therapeutics Inc|Kapitalizatsiyaning foydaga nisbati Harmony Corp HRMY|P/E multiplikatori BHVN|P/E multiplikatori amylyx.com (AMLX)|Narxning foydaga nisbati Trevi Therapeutics, Inc. TRVI|Kompaniya qiymatining sof foydaga nisbati PRAX|Anavex Corp - P/E multiplikatori|CBLL (CeriBell EEG) - Narx-foyda multiplikatori|PRTA (prothena.com) - Narx-foyda koeffitsiyenti|Alector - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Annexon|Omeros Corp. - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori NGNE|ACIU (AC Immune Inc) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori VYGR (Voyager Therapeutics)|P/E multiplikatori neumoratx.com NMRA|SCLX - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati TVGN (Tevogen Bio Holdings Inc.)|alphacognition.com (ACOG) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Cognition Therapeutics Inc.|IKT (Inhibikase Therapeutics) - P/E multiplikatori|P/E multiplikatori cassavasciences.com|P/E multiplikatori ASRT|Narx-foyda koeffitsiyenti coyatherapeutics.com COYA|P/E multiplikatori VTGN (Vistagen)|Ovid Therapeutics Inc (OVID) - Kapitalizatsiyaning foydaga nisbati|ABOS: Narx-foyda koeffitsiyenti|CRVO - P/E multiplikatori|ATHE (alteritytherapeutics.com) - Narx-foyda koeffitsiyenti|CLNN: Bozor narxining sof foydaga nisbati|PEPG (PepGen Inc) - P/E multiplikatori|Jupiter Neurosciences, Inc. (JUNS) - Biznesning o‘zini qoplash muddati|P/E multiplikatori RLMD|Narx-foyda koeffitsiyenti annovisbio.com ANVS|P/E multiplikatori GRCE (Grace Therapeutics)|P/E multiplikatori Firefly Neuroscience, Inc. AIFF|KLTO - Narxning foydaga nisbati|NRSN: Narxning foydaga nisbati|Reviva Pharmaceuticals (RVPH) - Narxning foydaga nisbati|MTVA - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati NeurAxis|Narxning foydaga nisbati HSDT|P/E multiplikatori PASG|Narxning foydaga nisbati NEUP (bionomics.com.au)|Narxning foydaga nisbati Minerva Neurosciences NERV|ATHA (athira.com) - Kapitalizatsiyaning sof foydaga nisbati|Addex Therapeutics Ltd - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati ALZN (Alzamend Neuro, Inc.)|cyclerion.com (CYCN) - Narxning foydaga nisbati|Narx-foyda multiplikatori PTIX|KTTA (Pasithea Therapeutics Corp) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Cortigent Medical CRGT|Narx-foyda koeffitsiyenti ATXI (Avenue Therapeutics, Inc.)|P/E multiplikatori Brainstorm Cell Therapeutics Inc. (BCLI)|Narxning foydaga nisbati Cara Therapeutics, Inc CARA|Kompaniya qiymatining sof foydaga nisbati CHRO|ELYM - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Intra-Cellular Therapies|Marinus Pharmaceuticals, Inc. (MRNS) - Narxning foydaga nisbati|NKGN (NKGen Biotech Inc) - Narxning foydaga nisbati|Narxning foydaga nisbati NeuroBo|Kapitalizatsiyaning foydaga nisbati Sage Therapeutics Inc SAGE|Narxning foydaga nisbati Synaptogenix, Inc. (SNPX)|trevena.com - Narx-foyda multiplikatori|P/E multiplikatori VIGL (Vigil Neuroscience, Inc.)|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti anewmeds.com|Cerevel - P/E multiplikatori